Literature DB >> 23242182

Investigation of rheumatoid arthritis genetic susceptibility markers in the early rheumatoid arthritis study further replicates the TRAF1 association with radiological damage.

Sebastien Viatte1, Darren Plant, Mark Lunt, Bo Fu, Edward Flynn, Ben J Parker, James Galloway, Csilla Solymossy, Jane Worthington, Deborah P M Symmons, Josh J Dixey, Adam Young, Anne Barton.   

Abstract

OBJECTIVE: The TRAF1 genetic region conferring susceptibility to rheumatoid arthritis (RA) has been reported to associate with radiological damage. We aimed to test RA genetic susceptibility markers for association with a continuous measure of radiological damage over time using longitudinal modeling techniques.
METHODS: Sixty-seven RA susceptibility variants were genotyped in 474 patients in the Early Rheumatoid Arthritis Study (ERAS) using Sequenom MassArray technology. Correlation between genetic markers and Larsen score was assessed longitudinally using zero-inflated negative binomial regression to include repeat measurements in the same individual at different timepoints. Genetic markers associated with radiological damage in ERAS were tested using the same modeling techniques on previously published data from the Norfolk Arthritis Register (NOAR).
RESULTS: The single marker associated longitudinally with Larsen score in ERAS (p = 0.02) and in NOAR (p = 0.04) was rs2900180 at the TRAF1 locus. Analysis of individual timepoints in ERAS showed that rs2900180 displays its effect primarily on the extent of Larsen score early in the disease course. Combined longitudinal analysis of the 2 cohorts suggests further association of several loci with Larsen score (KIF5A, PTPN22, AFF3, TAGAP) and therefore a significant accumulation of RA severity markers among RA susceptibility markers (p = 0.016).
CONCLUSION: The marker rs2900180 is associated with the extent of radiological damage in the ERAS cohort. This represents the second independent study correlating rs2900180 at the TRAF1 locus with radiological severity in RA. Replication in a large dataset is required to establish the role of other RA susceptibility loci in disease severity.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23242182     DOI: 10.3899/jrheum.121034

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  14 in total

1.  Spaceflight alters expression of microRNA during T-cell activation.

Authors:  Millie Hughes-Fulford; Tammy T Chang; Emily M Martinez; Chai-Fei Li
Journal:  FASEB J       Date:  2015-08-14       Impact factor: 5.191

2.  Do Genetic Susceptibility Variants Associate with Disease Severity in Early Active Rheumatoid Arthritis?

Authors:  Ian C Scott; Frühling Rijsdijk; Jemma Walker; Jelmar Quist; Sarah L Spain; Rachael Tan; Sophia Steer; Yukinori Okada; Soumya Raychaudhuri; Andrew P Cope; Cathryn M Lewis
Journal:  J Rheumatol       Date:  2015-05-15       Impact factor: 4.666

3.  NF-κB and Rheumatoid Arthritis: Will Understanding Genetic Risk Lead to a Therapeutic Reward?

Authors:  Robert Scheinman
Journal:  For Immunopathol Dis Therap       Date:  2013-04-01

Review 4.  The genetics of rheumatoid arthritis: risk and protection in different stages of the evolution of RA.

Authors:  Annie Yarwood; Tom W J Huizinga; Jane Worthington
Journal:  Rheumatology (Oxford)       Date:  2014-09-18       Impact factor: 7.580

5.  A genetic study on C5-TRAF1 and progression of joint damage in rheumatoid arthritis.

Authors:  Hanna W van Steenbergen; Luis Rodríguez-Rodríguez; Ewa Berglin; Alexandra Zhernakova; Rachel Knevel; Jose Ivorra-Cortés; Tom W J Huizinga; Benjamin Fernández-Gutiérrez; Peter K Gregersen; Solbritt Rantapää-Dahlqvist; Annette H M van der Helm-van Mil
Journal:  Arthritis Res Ther       Date:  2015-01-08       Impact factor: 5.156

6.  Association of HLA-DRB1 haplotypes with rheumatoid arthritis severity, mortality, and treatment response.

Authors:  Sebastien Viatte; Darren Plant; Buhm Han; Bo Fu; Annie Yarwood; Wendy Thomson; Deborah P M Symmons; Jane Worthington; Adam Young; Kimme L Hyrich; Ann W Morgan; Anthony G Wilson; John D Isaacs; Soumya Raychaudhuri; Anne Barton
Journal:  JAMA       Date:  2015-04-28       Impact factor: 56.272

7.  Investigation of Caucasian rheumatoid arthritis susceptibility loci in African patients with the same disease.

Authors:  Sebastien Viatte; Edward Flynn; Mark Lunt; Joanne Barnes; Madeleine Singwe-Ngandeu; Sylvette Bas; Anne Barton; Cem Gabay
Journal:  Arthritis Res Ther       Date:  2012-11-03       Impact factor: 5.156

8.  EM Adaptive LASSO-A Multilocus Modeling Strategy for Detecting SNPs Associated with Zero-inflated Count Phenotypes.

Authors:  Himel Mallick; Hemant K Tiwari
Journal:  Front Genet       Date:  2016-03-30       Impact factor: 4.599

9.  Loci associated with N-glycosylation of human IgG are not associated with rheumatoid arthritis: a Mendelian randomisation study.

Authors:  Annie Yarwood; Sebastien Viatte; Yukinori Okada; Robert Plenge; Kazuhiko Yamamoto; Anne Barton; Deborah Symmons; Soumya Raychaudhuri; Lars Klareskog; Peter Gregersen; Jane Worthington; Steve Eyre
Journal:  Ann Rheum Dis       Date:  2015-09-17       Impact factor: 19.103

10.  Association Between Genetic Variation in FOXO3 and Reductions in Inflammation and Disease Activity in Inflammatory Polyarthritis.

Authors:  Sebastien Viatte; James C Lee; Bo Fu; Marion Espéli; Mark Lunt; Jack N E De Wolf; Lily Wheeler; John A Reynolds; Madhura Castelino; Deborah P M Symmons; Paul A Lyons; Anne Barton; Kenneth G C Smith
Journal:  Arthritis Rheumatol       Date:  2016-11       Impact factor: 10.995

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.